TherapeuticsMD Announces FDA Approval of TX-004HR: IMVEXXY™ (estradiol vaginal inserts), the Lowest Dose Vaginal Estrogen Product Approved for the Treatment of Moderate to Severe Dyspareunia, a Symp
Go back to TherapeuticsMD Announces FDA Approval of TX-004HR: IMVEXXY™ (estradiol vaginal inserts), the Lowest Dose Vaginal Estrogen Product Approved for the Treatment of Moderate to Severe Dyspareunia, a Symp| THERAPEUTICSMD, Inc. (NASDAQ: TXMD) | Delayed: 2.11 +0.08 (3.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.03 | 52 Week High | $11.26 | |||
| Open | $2.01 | 52 Week Low | $4.39 | |||
| Day High | $2.15 | P/E | N/A | |||
| Day Low | $2.01 | EPS | $-0.22 | |||
| Volume | 50,905 | |||||
